Gobert et al. reported that Tregs in breast cancer can selectively aggregate via CCR4, preventing effector T-cell activation and ultimately leading to immune escape and tumor progression, indicating that Tregs infiltration may associated with a poor prognosis [36]. The gene discussed is CCR4; the disease is breast cancer.